4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Left ventricular ejection fraction (EF) remains the major parameter for diagnosis,
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …

Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …

Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Aims This study evaluated the prognosis and prognostic factors of patients with cardiac
sarcoidosis (CS), an underdiagnosed disease. Methods and results Patients from a …

Heart failure affects over 2.6 million women and 3.4 million men in the United States with
known sex differences in epidemiology, management, response to treatment, and outcomes …

The prevalence of sarcoidosis-related cardiomyopathy is increasing. Sarcoidosis impacts
cardiac function through granulomatous infiltration of the heart, resulting in conduction …

Aims Giant cell myocarditis (GCM) is an inflammatory cardiomyopathy akin to cardiac
sarcoidosis (CS). We decided to study the findings of GCM on cardiac magnetic resonance …

Myocarditis is most recognized in patients with moderate to severe, recent‐onset heart
failure. However, less typical presentations including myocardial infarction with normal …

Restrictive cardiomyopathy (RCM) is a heterogeneous group of diseases characterized by
restrictive left ventricular pathophysiology, ie a rapid rise in ventricular pressure with only …